Scribe Therapeutics, Inc. IPO Review

Scribe Therapeutics, Inc. IPO Pages

Scribe Therapeutics, Inc. IPO Scribe Therapeutics, Inc. IPO Review
📝

Detailed review coming soon

Our editorial team is preparing an in-depth analysis of Scribe Therapeutics, Inc. IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.

Price / Issue Price
$15
Issue Size
$128 M
Type
Mainboard
Exchange
Nasdaq
Sector
Healthcare & Pharma
Already listed.

IPO Details

Type
Mainboard
Country
United States
Sector
Healthcare & Pharma

Related IPOs